Mereo BioPharma - Aset Bersih saben Siji Saham MREO

Mereo BioPharma (MREO) focuses on therapies for rare pathologies, leveraging patent protection to maintain pricing power within unique niches. Capital stability is supported by advances from global partners, which has minimized the burn rate, with the current figure standing at 0.18. Growth is driven by osteogenesis developments and acquisition prospects. This price chart on the GURU.Markets platform clearly demonstrates the dynamics of this biotech business.

Mereo BioPharma - Aset Bersih saben Saham MREO (periode 04.07.2022 - 27.10.2026)

Ringkesan rincian data analitis Mereo BioPharma Group (MREO)

- rega lan prakiraan konsensus rega:

Rega saham Mereo BioPharma Group PLC|MREO - Rata-rata rega prakiraan

- data kapitalisasi pasar:

Nilai pasar Mereo BioPharma Group plc|MREO - Total Nilai Perusahaan

- data kapitalisasi buku:

Aset Bersih saben Siji Saham Mereo BioPharma|MREO - Pambiji Buku Bisnis|Rasio Nilai Pasar marang Nilai Buku mereobiopharma.com|MREO - Nilai Total Aset Perusahaan

- data utang lan likuiditas:

Total Utang marang Modal Mereo BioPharma|MREO - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang modal Mereo BioPharma Group PLC|MREO - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Mereo BioPharma Group plc

Analisis kabeh metrik perusahaan:mereobiopharma.com MREO

Book value per share reflects the organization's net assets minus liabilities, serving as a fundamental measure of real assets per share. Analyzing the historical book value trend of Mereo BioPharma (MREO), an investor can see the capital stability of this biotech startup, whose small operational footprint and strict adherence to environmental regulations minimize unforeseen costs, confirming the company's strong financial foundation.

Pesaing Mereo BioPharma (MREO)